Research Article 
Health utility values associated with diabetic retinopathy
A. Lloyd, B. Nafees, S. Gavriel, M. D. Rousculp, K. S. Boye and A. Ahmad
Diabetic Medicine, 2008, 25(5), 618-624. DOI: 10.1111/j.1464-5491.2008.02430.x
Abstract
Aims Different estimates exist regarding the impact of diabetic retinopathy (DR) on health utility. A previously reported prospective observational study has reported much larger decrements in self-reported utility than generic utility data from the UK Prospective Diabetes Study and the Lipids in Diabetes Study. The present study was designed to estimate utility loss using multiple methods.
Methods Detailed health state descriptions reflecting declining DR (five different visual acuity levels), neuropathy and nephropathy were validated with patients and used to elicit utility values from people with DR, people with diabetes and members of the UK general public using standard gamble. In addition, a larger sample of people with retinopathy completed different health-related quality of life measures in an interview [EuroQoL (EQ-5D), Health State Utilities Index (HUI)-3, and National Eye Institute Visual Functioning Questionnaire-25].
Results The utility scores from the standard gamble interviews were not significantly different between the three groups. There was a decline in utility from 6/6 vision to counting fingers of −0.244. The utility data derived from the generic measures revealed an equivalent decline of −0.41 on both the EQ-5D single index and the HUI-3.
Conclusions This study has re-examined the utility decrements associated with DR and has identified much larger declines in utility than previously reported. The study has also reported the utility values of patients with retinopathy as assessed by standard gamble. We believe that this may be the first study to report utility values for health states associated with vision loss which have been elicited from patients with vision loss.
ASCI-ID: 109-134
Similar Articles
Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population—the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4
Diabetic Medicine, 2008, 25(5), 536-542. DOI: 10.1111/j.1464-5491.2008.02423.x
The Y402H variant of complement factor H is associated with age-related macular degeneration but not with diabetic retinal disease in the Go-DARTS studyDiabetic Medicine, 2009, 26(5), 460-465. DOI: 10.1111/j.1464-5491.2009.02719.x
Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age populationDiabetic Medicine, 2009, 26(5), 489-492. DOI: 10.1111/j.1464-5491.2009.02718.x
Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programmeDiabetic Medicine, 2009, 26(10), 1040-1047. DOI: 10.1111/j.1464-5491.2009.02820.x
Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetesDiabetic Medicine, 2010, 27(4), 431-435.
Is risk of diabetic retinopathy lower in Australia’s Greek-born migrants?Diabetic Medicine, 2010, 27(6), 660-665. DOI: 10.1111/j.1464-5491.2010.03005.x
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT ProgrammeDiabetic Medicine, 2011, 28(3), 345-351. DOI: 10.1111/j.1464-5491.2010.03210.x
Increased levels of monokine induced by interferon-γ (Mig) in the vitreous of patients with diabetic retinopathyDiabetic Medicine, 2008, 25(7), 875-877. DOI: 10.1111/j.1464-5491.2008.02466.x
Reliability of screening methods for diabetic retinopathyDiabetic Medicine, 2009, 26(8), 783-790. DOI: 10.1111/j.1464-5491.2009.02778.x
Blood pressure control and awareness among patients with diabetes and hypertension attending a tertiary ophthalmic clinicDiabetic Medicine, 2009, 26(1), 34-39. DOI: 10.1111/j.1464-5491.2008.02614.x
Diabetic retinopathy screening: a systematic review of the economic evidenceDiabetic Medicine, 2010, 27(3), 249-256. DOI: 10.1111/j.1464-5491.2009.02870.x
Socio-economic and ethnic inequalities in diabetes retinal screeningDiabetic Medicine, 2010, 27(3), 282-288. DOI: 10.1111/j.1464-5491.2010.02946.x
Association between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem StudyDiabetic Medicine, 2010, 27(10), 1130-1137. DOI: 10.1111/j.1464-5491.2010.03080.x
Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathyDiabetic Medicine, 2011, 28(6), 741-746. DOI: 10.1111/j.1464-5491.2011.03273.x
Do type 2 diabetes patients without diabetic retinopathy or subjects with impaired fasting glucose have impaired colour vision? The Okubo Color Study ReportDiabetic Medicine, 2011, 28(7), 865-871. DOI: 10.1111/j.1464-5491.2011.03290.x
External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening ProgrammeDiabetic Medicine, 2012, 29(6), 776-783. DOI: 10.1111/j.1464-5491.2011.03504.x
Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experimentDiabetic Medicine, 2012, 29(7), 869-877. DOI: 10.1111/j.1464-5491.2012.03636.x
Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screeningDiabetic Medicine, 2012, 29(7), 878-885. DOI: 10.1111/j.1464-5491.2012.03637.x
Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countriesDiabetic Medicine, 2013, 30(4), 387-398. DOI: 10.1111/dme.12119
Systematic literature review: quality of life associated with insulin pump use in Type 1 diabetesDiabetic Medicine, 2007, 24(6), 607-617. DOI: 10.1111/j.1464-5491.2007.02120.x
Investigation of quality of life and family burden issues during insulin pump therapy in children with Type 1 diabetes mellitus—a large-scale multicentre pilot study1Diabetic Medicine, 2009, 26(5), 493-501. DOI: 10.1111/j.1464-5491.2009.02707.x
Patient-reported outcomes following islet cell or pancreas transplantation (alone or after kidney) in Type 1 diabetes: a systematic reviewDiabetic Medicine, 2010, 27(7), 812-822. DOI: 10.1111/j.1464-5491.2010.03029.x
Initiation of insulin glargine in patients with Type 2 diabetes in suboptimal glycaemic control positively impacts health-related quality of life. A prospective cohort study in primary careDiabetic Medicine, 2011, 28(9), 1096-1102. DOI: 10.1111/j.1464-5491.2011.03329.x
Quality of life and treatment satisfaction in adults with Type 1 diabetes: a comparison between continuous subcutaneous insulin infusion and multiple daily injectionsDiabetic Medicine, 2008, 25(2), 213-220. DOI: 10.1111/j.1464-5491.2007.02346.x
Quality of life in children with Type 1 diabetes: a comparison of general and diabetes-specific measures and support for a unitary diabetes quality-of-life constructDiabetic Medicine, 2008, 25(11), 1316-1323. DOI: 10.1111/j.1464-5491.2008.02574.x
Not all roads lead to Rome-a review of quality of life measurement in adults with diabetesDiabetic Medicine, 2009, 26(4), 315-327. DOI: 10.1111/j.1464-5491.2009.02682.x
Randomized trial of custom orthoses and footwear on foot pain and plantar pressure in diabetic peripheral arterial diseaseDiabetic Medicine, 2009, 26(9), 893-899. DOI: 10.1111/j.1464-5491.2009.02799.x
Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetesDiabetic Medicine, 2010, 27(5), 578-584. DOI: 10.1111/j.1464-5491.2010.02971.x
People living with diabetes resident in nursing homes-assessing levels of disability and nursing needsDiabetic Medicine, 2011, 28(7), 778-780. DOI: 10.1111/j.1464-5491.2011.03261.x
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative reviewDiabetic Medicine, 2012, 29(3), 293-302. DOI: 10.1111/j.1464-5491.2011.03416.x
Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare-China studiesDiabetic Medicine, 2012, 29(4), 515-521. DOI: 10.1111/j.1464-5491.2011.03436.x
Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetesDiabetic Medicine, 2012, 29(6), 716-720. DOI: 10.1111/j.1464-5491.2011.03547.x